140 likes | 151 Views
The Global Infertility Drugs Market size was valued at US$ 3.8 billion in 2017.
E N D
Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker
INFERTILITY DRUGS MARKET ANALYSIS Infertility Drugs Market,ByDrug Type (Clomiphene citrate, Sex hormones, Gonadotropins, Bromocriptine, Cabergoline, Imipramine, Letrozole, and Metformin), By Route of Administration (Oral, Intravenous, Subcutaneous, and Intramuscular), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2026
The global infertility drugs market size was valued at US$ 3.8 billion in 2017, and is expected to witness a CAGR of 5.8% over the forecast period (2019 – 2026). Drivers • The infertility drugs market size is expected to witness significant growth, owing to the rising research and developmental studies for more effective treatment to achieve pregnancy and live births. For instance, in 2014, a team of researchers at National Institutes of Health’s (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) found that women treated with Letrozole have high rates of ovulation and live births than women treated with the standard drug, Clomiphene. Furthermore, among women who received Letrozole, 27.5% of them eventually had a live birth and women who received clomiphene, only 19.1% them experienced a live birth. The cumulative ovulation rate was higher for the Letrozole group, with ovulation occurring 61.7% of the time, and the women in the clomiphene group ovulated 48.3% of the time.
Moreover, rising prevalence of lifestyle disorders and unhealthy diet such as obesity, stress, smoking, diabetes, Poly Cystic Ovarian Syndrome (PCOS) and etc. also leads to infertility, eventually rising demand for infertility drugs. According to a study published in National Center for Biotechnology and Information (NCBI) 2015 report, smoking was associated with decrease in sperm density by 15.3%, total sperm counts by 17.5%, and total motile sperm by 16.6% compared with nonsmokers in China.
Global Infertility Drugs Market Share (%) Analysis, By Product Type, 2018
Market Restraints The infertility drugs market growth is hindered by the side effects shown by the drugs including headache, nausea, upper respiratory tract infection, abdominal tenderness, sinus congestion, mood swings, acne, breast tenderness, weight gain, pelvic discomfort, abnormal bleeding or spotting, vomiting, injection site pain, redness, dizziness and Ovarian Hyper-Stimulation Syndrome (OHSS). According to a study published in NCBI, in 2016, up to 10% to 20% of women who consume infertility drugs can develop a mild form of OHSS, which will usually resolve on its own. Severe cases of OHSS occurs in less than one percent of patients in the U.S.
Regional Insights • On the basis of region, the global infertility drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global infertility drugs market size, owing to the rising number of new Food and Drug Administration (FDA) infertility drug approvals over the forecast period. For instance, in 2018, ZydusCadila launched generic Vardenafil Hydrochloride tablets used for the treatment of erectile dysfunction in the U.S. The company has launched the tablets in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg.
Asia Pacific infertility drugs market size is expected to foresee a rapid growth in the market, owing to rise in research and development activities for better reproductive health. For instance, in 2018, Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) announced a long-term collaboration to advance basic and translational research in reproductive medicine through the development of novel product candidates and therapeutic strategies.
Global Infertility Drugs Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2026
Competitive Section Key players operating in the global infertility drugs market include Merck & Co., Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., Abbott Laboratories, Bayer AG, and Zydus Pharmaceuticals.
Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst Reference: https://www.coherentmarketinsights.com/market-insight/infertility-drugs-market-2665
About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis
Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com
Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/